Purple Biotech (PPBT) Interest Expenses (2014 - 2026)
Purple Biotech (PPBT) posted quarterly Interest Expenses of $31000.0 for Q1 2026, down 11.43% year-over-year from $35000.0 in Q1 2025, and down 85.51% quarter-over-quarter from $214000.0 in Q4 2025.
Purple Biotech (PPBT) Interest Expenses (2014 - 2026) Analysis & Trends
Purple Biotech (PPBT) has reported Interest Expenses for 12 consecutive years, with $31000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Interest Expenses fell 11.43% year-over-year to $31000.0; the TTM figure through Mar 2026 stood at $275000.0 (down 45.11% YoY), while the FY2025 annual figure was $982000.0, up 103.31% from the prior year.
- Interest Expenses fell to $31000.0 in Q1 2026 per PPBT's latest filing, from $214000.0 in the prior quarter.
- Across five years, Interest Expenses topped out at $2.1 million in Q4 2023 and bottomed at -$69000.0 in Q4 2024.
- Historically, Interest Expenses has averaged $190058.8 across 5 years, with a median of $31000.0 in 2026.
- Annual changes were most pronounced in 2023 — Interest Expenses soared 11505.56% — and 2024, when it slumped 103.3%.
- Purple Biotech's Interest Expenses stood at $18000.0 in 2022, then jumped by 11505.56% to $2.1 million in 2023, then slumped by 103.3% to -$69000.0 in 2024, then surged by 410.14% to $214000.0 in 2025, then slumped by 85.51% to $31000.0 in 2026.
- Business Quant data shows PPBT's Interest Expenses at $31000.0 in Q1 2026, $214000.0 in Q4 2025, and $5000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 11.00 Mn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 39.74 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 82.05 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 20.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 93.62 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -4.89 Mn |
| 10 | Purple Biotech | 133.62 | 133.62 | - | 9,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 31,000.00 |
| Mar 31, 2026 | 31,000.00 |
| Dec 31, 2025 | 214,000.00 |
| Dec 31, 2025 | 214,000.00 |
| Sep 30, 2025 | 5,000.00 |
| Sep 30, 2025 | 5,000.00 |
| Jun 30, 2025 | 25,000.00 |
| Jun 30, 2025 | 25,000.00 |
| Mar 31, 2025 | 35,000.00 |
| Mar 31, 2025 | 35,000.00 |
| Dec 31, 2024 | -69,000.00 |
| Dec 31, 2024 | -69,000.00 |
| Sep 30, 2024 | 511,000.00 |
| Sep 30, 2024 | 511,000.00 |
| Jun 30, 2024 | 24,000.00 |
| Jun 30, 2024 | 24,000.00 |
| Mar 31, 2024 | 17,000.00 |
| Mar 31, 2024 | 17,000.00 |
| Dec 31, 2023 | 2.09 Mn |
| Dec 31, 2023 | 2.09 Mn |